S&P upgrades Aspirus' rating to 'AA-'

S&P Global Ratings upgraded  its long-term rating on  Wausau, Wis.-based Aspirus from "A+" to "AA-."

S&P also raised its underlying rating for the system's variable-rate demand bonds from "A+" to "AA-."

The ratings reflect Aspirus' sound financial profile, with good debt and liquidity metrics even considering recent capital projects, along with the health system's growth in recent years.

The rating outlook is stable.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars